Efficacy and safety of twice-daily aclidinium bromide in COPD patients: The ATTAIN study

Paul W. Jones, Dave Singh, Eric D. Bateman, Alvar Agusti, Rosa Lamarca, Gonzalo De Miquel, Rosa Segarra, Cynthia Caractae, Esther Garcia Gi

    Research output: Contribution to journalArticlepeer-review

    Fingerprint

    Dive into the research topics of 'Efficacy and safety of twice-daily aclidinium bromide in COPD patients: The ATTAIN study'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science